Lv1
82 积分 2024-07-15 加入
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
4天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
13天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
18天前
已完结
Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators
1个月前
已完结
A deep generative model for molecule optimization via one fragment modification
1个月前
已完结
On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations
1个月前
已完结
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
1个月前
已完结
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition
1个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
2个月前
已完结
Target-Specific De Novo Peptide Binder Design with DiffPepBuilder
3个月前
已完结
皖公网安备34019202002308
